ERBB2 and neoplasm: Critically, transgenic mice expressing HER2-M611 have a greater number of tumors with a larger volume and more aggressive growth compared to mice overexpressing full-length HER2, whereas HER2-M687 overexpression does not result in tumor formation, with the mammary glands being comparable to control mice [11].